Final Thoughts: The Right Fit for Your Fitness Path If you prefer fasted cardio, value workout endurance, and want energy without stimulants, L-Carnitine may be your go-to choice
Amyloidosis in Alzheimer's disease: pathogeny, etiology, and related therapeutic directions
Kwak HJ, Song JS, No ZS, Song JH, Yang SD, Cheon HG
The development and refinement of a class of medications known as GLP-1 receptor agonists have completely changed the conversation
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
Doses are given once per week, ideally on the same day and time